Drugs / BI 860585
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01938846 | Sep 2013 → Jul 2016 | neoplasm | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 860585 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01938846 ↗ |
| Route | Oral | “BI 860585 Administered Orally” NCT01938846 ↗ |